Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Camilla V. Myklebust
University of Oslo - KG Jebsen Centre for B Cell Malignancies
Norway
Contact
University of Oslo - KG Jebsen Centre for B Cell Malignancies
Email
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
56
TOTAL CITATIONS
1
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Preexisting Cross-Reactive T Cells are Boosted and Comprise Significant Immunity in COVID-19 Recovered Patients
Number of pages: 55
Posted: 24 Feb 2021
Camilla V. Myklebust,
Jamie Piers York
,
Katrine Persgård Lund
,
Gunnveig Grødeland
,
Anders Tveita
,
Lise Sofie Nissen-Meyer
,
Fridtjof Lund-Johansen
,
Arne Søraas
,
Unni C. Nygaard
,
Siri Mjaaland
,
John Torgils Vaage
and
Ludvig André Munthe
University of Oslo - KG Jebsen Centre for B Cell Malignancies, University of Oslo - KG Jebsen Centre for B Cell Malignancies, University of Oslo - KG Jebsen Centre for B Cell Malignancies, University of Oslo - Institute of Clinical Medicine, Vestre Viken Hospital Trust, Oslo University Hospital - Department of Immunology, University of Oslo - Department of Immunology and Transfusion Medicine, Oslo University Hospital - Department of Microbiology, Norwegian Institute of Public - Department of Infectious Disease Surveillance and Environmental Health, Norwegian Institute of Public Health - Department of Method Development and Analytics, University of Oslo - Institute of Clinical Medicine and University of Oslo - KG Jebsen Centre for B Cell Malignancies
Downloads
56
(1,000,027)
Citation
1
View PDF
Download
Abstract:
Feedback